The nation of Zimbabwe has rejected a major US health deal valued at $367m (£272m) spanning five years because of the United States' request for confidential data.
This move came to light after a government memo from December was leaked, indicating that President Emmerson Mnangagwa believed the agreement was "unbalanced".
An official representative later explained that the US was demanding access to genetic material for scientific study and profit but was unwilling to share the benefits from any future medical innovations.
"We will now turn to the difficult and regrettable process of winding down our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for continued dialogue to reach a agreement agreeable to all parties so the nation's vital HIV treatment initiative can be sustained.
Broader Context
This development follows a comparable case in Kenya, where a high court suspended a related health funding agreement following legal challenges were filed about the safety of Kenyans' health data.
After returning to the presidency recently, US President Donald Trump has slashed overseas assistance and shut down the US Agency for International Development (USAID).
The agency had overseen assistance for the American government, but Trump stated its spending was "wasteful" and his administration was pursuing direct bilateral agreements to enhance transparency and responsibility.
Based on statements, 16 African countries have to date agreed to similar agreements, representing over $18.3bn in new funding.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"We believe this cooperation might have yielded immense advantages for the people of Zimbabwe, particularly the 1.2 million currently receiving HIV treatment through American-funded programmes," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data indefinitely, with no corresponding promise of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that provided information," his statement read.
"Effectively, our nation would provide the basic resources for scientific discovery with no assurance that the resulting innovations would be accessible to our people if a future pandemic arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its push of one-on-one deals were upending frameworks already set up via the global health agency.
The spokesperson gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage potential pandemics.
"This mechanism is intended to guarantee that when a country contributes its data, the benefits – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," he added.
"We encourage ongoing dialogue with our American counterparts on how future collaboration could be designed in a way that respects the sovereignty and dignity of both nations."
Medical Community Reaction
Medical experts said it acknowledged the government's concerns, but urged that negotiations should continue since a large portion of the nation's Aids initiatives relied on international support.
"In cases where specific concerns exist, such as those relating to data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group said.
The situation underscores the continuing debate between receiving much-needed international aid and protecting national sovereignty in an increasingly interconnected world.